PFIZER BUPIVACAINE 0.5% w/v WITH ADRENALINE (epinephrine) 1:200,000 injection solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer bupivacaine 0.5% w/v with adrenaline (epinephrine) 1:200,000 injection solution vial

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 5.27 mg/ml (equivalent: bupivacaine hydrochloride, qty 5 mg/ml); adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; citric acid; sodium citrate - pfizer bupivacaine with adrenaline injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows;,surgical anaesthesia:,- epidural block for surgery,- field block (minor and major nerve blocks and infiltration),analgesia,- continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain,- field block (minor nerve block and infiltration),the choice of 2 strengths, 0.25%, and 0.5% makes it possible to vary the degree of motor blockade.

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (100mg/20mL) injection BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (australia) bupivacaine hydrochloride 0.5% (100mg/20ml) injection bp vial

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

METARAMINOL JUNO metaraminol (as tartrate) 2.5 mg/5 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol juno metaraminol (as tartrate) 2.5 mg/5 ml solution for injection pre-filled syringe

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 4.744 mg (equivalent: metaraminol, qty 2.5 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; dilute hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL JUNO metaraminol (as tartrate) 5 mg/10 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

metaraminol juno metaraminol (as tartrate) 5 mg/10 ml solution for injection pre-filled syringe

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.488 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; dilute hydrochloric acid; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

TERLIPRESSIN EVER PHARMA terlipressin 1.7 mg/10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

terlipressin ever pharma terlipressin 1.7 mg/10 ml solution for injection vial

interpharma pty ltd - terlipressin, quantity: 1.7 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

TERLIPRESSIN EVER PHARMA terlipressin 0.85 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

terlipressin ever pharma terlipressin 0.85 mg/5 ml solution for injection vial

interpharma pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

Bridgewest LIDOCAINE INJECTION 1% 200 mg/20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 1% 200 mg/20 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 1% 50 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 1% 50 mg/5 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 2% 400 mg/20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 2% 400 mg/20 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 2% 100 mg/5 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.